IVD Trends to Watch: AI and the Future of Digital Pathology

Artificial intelligence (AI) is growing at a fast pace due to the adoption of AI-based technologies. There is a move toward connected health, which includes AI. AI has proved to be an invaluable tool in assisting physicians in caring for their patients. The advanced capabilities of algorithms are serving to reduce workloads and provide testing […]

Dynamic Landscape for Cell and Gene Therapy in 2024

2024 is an exciting time to be involved in the cell and gene therapy (CGT) industry. With rapid advancements in science, the industry is on the cusp of industrializing and standardizing the manufacturing and commercialization of CGT products. The future points toward standardized setups and more automated systems. However, the broad nature of the field […]

How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies

In the dynamic laboratory diagnostics industry, staying ahead means having smart strategies in place. Market research is the secret ingredient that fuels successful go-to-market (GTM) plans. It helps you understand your audience, outshine competitors, and make informed decisions. In this blog, we explore how market research supercharges different parts of your GTM strategy for success […]

4 Key Components to a Winning Go-To-Market Strategy

Crafting a successful go-to-market (GTM) strategy in the laboratory diagnostic industry requires strategic planning and meticulous execution. It’s more than just bringing a product to market—it’s about aligning your offering with market needs, targeting the right audience, and positioning your brand for success. In this blog, we explore the essential steps and strategies necessary to […]

Immunoassays: A $27 Billion Market of Intrigue and Opportunity

The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]

IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth

In Egypt, like many other countries, the elderly population is growing rapidly, increasing at a rate of 5.1% annually, which is more than double the growth rate of the total population. This demographic shift, coupled with a large rural population requiring satellite care and mobile services, poses significant challenges for the healthcare system, according to […]

Momentum in Multiplex Testing for IVD

Diagnostic testing is now a cornerstone of healthcare, assisting physicians in diagnosing conditions and prescribing treatments. Demand for in vitro diagnostic (IVD) testing has remained strong across various segments, with sales generally increasing throughout 2023. Global IVD market sales surpassed $100 billion in 2023, according to In Vitro Diagnostic (IVD) Trends and Market Update: March […]

Defining the Molecular Point of Care (mPOC) Market in 2024

Defining the molecular point of care (mPOC) market is the first step in market-sizing this segment. The mPOC market refers to the use of molecular diagnostic tests at or near the patient’s location to enable rapid and actionable clinical decisions. These tests typically involve the detection of nucleic acids (DNA or RNA) from pathogens or […]

Cancer, Obesity, Diabetes, and Cardiovascular Disease Drive South Korea’s IVD Investment

South Korea ranks as the fifth largest health market in the Asia Pacific region, following China, Japan, Australia, and India.. South Korea’s investment in healthcare, medical devices, and diagnostics is driven by the burden of obesity, diabetes, cardiovascular disease, and cancer. The country’s business environment for medical devices and equipment is favorable and streamlined for […]

Non-COVID-19 Vaccines Get Post-Pandemic Boost

Infectious diseases are some of the deadliest diseases that pose a significant risk to human life. Since the advent of the pandemic, scientists worldwide have intensified research and development of preventative vaccines that will hopefully combat existing and new infectious disease threats. Because of this dedicated focus, the global market for human preventive vaccines experienced […]